OSM and relapsing-remitting multiple sclerosis: Oncostatin M, encoded by the Osm gene was found upregulated in the serum of a cohort of people with relapsing-remitting MS [44], while oncostatin treatment protected against demyelination in the Cuprizone-induced demyelination model [45].